Anticancer research, 0250-7005

Journal

1 - 10 out of 12Page size: 10

Publications

  1. 2017
  2. Published

    A study of angiogenesis markers in patients with renal cell carcinoma undergoing therapy with sunitinib

    Sarah Pirrie & Emilio Porfiri, 1 Jan 2017, In: Anticancer research. 37, 1, p. 253-259 7 p.

    Research output: Contribution to journal › Article › peer-review

  3. 2016
  4. Published

    Outcomes Following Interval Debulking Surgery in Primary Peritoneal Carcinoma

    Sudha Sundar, 1 Jan 2016, In: Anticancer research. 36, 1, p. 255-259 5 p.

    Research output: Contribution to journal › Article › peer-review

  5. 2015
  6. Published

    Survival and toxicity following chemoradiation for carcinoma of the cervix - Impact of multiple-phase treatment and shielding

    Sarah Pirrie, 1 Oct 2015, In: Anticancer research. 35, 10, p. 5567-5574 8 p.

    Research output: Contribution to journal › Article › peer-review

  7. Published

    The In Vitro and In Vivo Activity of the Microtubule Disruptor STX140 Is Mediated by Hif-1 Alpha and CAIX Expression

    Paul Foster, Oct 2015, In: Anticancer research. 35, 10, p. 5249-61 13 p.

    Research output: Contribution to journal › Article › peer-review

  8. Published

    Predictive factors for response to abiraterone in metaststic castration refractory prostate cancer

    Sarah Pirrie, Nicholas James, Feb 2015, In: Anticancer research. 35, 2, p. 1057-1063 7 p.

    Research output: Contribution to journal › Article › peer-review

  9. 2012
  10. Published

    Gene expression and protein array studies of folliculin-regulated pathways

    Xiaohong Lu, Laurence Seabra, Michael Nahorski, Wenbin Wei & Eamonn Maher, Nov 2012, In: Anticancer research. 32, 11, p. 4663-70

    Research output: Contribution to journal › Article › peer-review

  11. 2009
  12. Published

    Mutation Analysis of Hypoxia-inducible Factors HIF1A and HIF2A in Renal Cell Carcinoma

    Mark Morris, Christopher Ricketts, Farida Latif & Eamonn Maher, 1 Nov 2009, In: Anticancer research. 29, 11, p. 4337-4343 7 p.

    Research output: Contribution to journal › Article

  13. Published

    STX140 and STX641 cause apoptosis via the intrinsic mitochondrial pathway and down-regulate survivin and XIAP expression in ovarian and prostate cancer cells

    Paul Foster, 2009, In: Anticancer research. 29, 10, p. 3751-7 7 p.

    Research output: Contribution to journal › Article › peer-review

  14. 2008
  15. Published

    A comparison of two orally bioavailable anti-cancer agents, IRC-110160 and STX140

    Paul Foster, 2008, In: Anticancer research. 28, 3A, p. 1483-91 9 p.

    Research output: Contribution to journal › Article › peer-review

  16. Published

    A new micronized formulation of 2-methoxyestradiol-bis-sulfamate (STX140) is therapeutically potent against breast cancer

    Paul Foster, 2008, In: Anticancer research. 28, 2A, p. 577-81 5 p.

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 Next